Eileen Baildam

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Fabrizio De Benedetti, Hermine I. Brunner, Nicolino Ruperto et al. · New England Journal of Medicine · 2012 · 873 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +15

Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>

Yanick J. Crow, Diana Chase, Johanna L. Schmidt et al. · American Journal of Medical Genetics Part A · 2015 · 613 citations · Full text

Life Sciences, Genetics, Molecular Genetics +9

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

Gillian Rice, Yoandris del Toro Duany, Emma M. Jenkinson et al. · Nature Genetics · 2014 · 591 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto, Daniel J. Lovell, Rubén Cuttica et al. · Arthritis & Rheumatism · 2007 · 411 citations

Medicine, Pediatrics, Pharmacotherapy +12

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

Nicolino Ruperto, Kevin Murray, V. Gerloni et al. · Arthritis & Rheumatism · 2004 · 374 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +10